$ARQT insider trading
Over the last 12 months, Arcutis Biotherapeutics insiders reported no purchases and 52 sales totaling $16.2M across SEC Form 4 filings. 87% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $16.2M 52 events
- Events · 12m
- 52 Form 4 filings, grouped
- Insiders · 12m
- 11 distinct reporters
- 10b5-1 share
- 87% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Matsuda MasaruSee Remarks · O | ▼ Sale | 3,674 | $25 | $92K | -3.2% | plan |
| Sep 15, 2026 | Welgus Howard G.D | ▼ Sale | 4,730 | $24.18 | $114K | -11.7% | plan |
| Sep 8, 2026 | Matsuda MasaruSee Remarks · O | ▼ Sale | 9,989 | $25.03 | $250K | -7.9% | plan |
| Aug 27, 2026 | Curran TerrieD | ▼ Sale | 38,200 | $25.03 | $956K | -61.9% | 2 tranches |
| Aug 20, 2026 | Curran TerrieD | ▼ Sale | 1,072 | $26.04 | $28K | -4.4% | — |
| Aug 19, 2026 | Burnett PatrickSee Remarks · O | ▼ Sale | 1,697 | $27 | $46K | -1.4% | — |
| Aug 17, 2026 | Welgus Howard G.D | ▼ Sale | 4,730 | $26.18 | $124K | -11.5% | plan |
| Aug 12, 2026 | Burnett PatrickSee Remarks · O | ▼ Sale | 15,000 | $26.33 | $395K | -11.2% | 2 tranches |
| Aug 3, 2026 | Burnett PatrickSee Remarks · O | ▼ Sale | 955 | $26.12 | $25K | -0.8% | plan |
| Aug 3, 2026 | Matsuda MasaruSee Remarks · O | ▼ Sale | 1,230 | $26.12 | $32K | -1% | plan |
| Aug 3, 2026 | Watanabe ToddSee Remarks · O·D | ▼ Sale | 4,375 | $26.12 | $114K | -0.6% | plan |
| Jul 15, 2026 | Welgus Howard G.D | ▼ Sale | 4,730 | $26.91 | $127K | -11.3% | plan |
| Jun 17, 2026 | Welgus Howard G.D | ▼ Sale | 4,731 | $24.58 | $116K | -11.1% | plan · 2 tranches |
| Jun 15, 2026 | LIN SUE-JEAND | ▼ Sale | 4,946 | $24.38 | $121K | -15.2% | plan |
| May 4, 2026 | Vairavan LathaSVP Chief Financial Officer · O | ▼ Sale | 1,341 | $23.61 | $32K | -1.5% | plan |
| May 4, 2026 | Watanabe ToddSee Remarks · O·D | ▼ Sale | 3,172 | $23.61 | $75K | -0.4% | plan |
| May 4, 2026 | Matsuda MasaruSee Remarks · O | ▼ Sale | 8,256 | $23.31 | $192K | -6.1% | plan · 2 tranches |
| May 4, 2026 | Burnett PatrickSee Remarks · O | ▼ Sale | 684 | $23.61 | $16K | -0.6% | plan |
| May 1, 2026 | Welgus Howard G.D | ▼ Sale | 7,144 | $22.99 | $164K | -18% | plan |
| Apr 1, 2026 | Welgus Howard G.D | ▼ Sale | 10,000 | $23.88 | $239K | -20.1% | plan |
| Mar 2, 2026 | Leonard Keith RD | ▼ Sale | 39,272 | $25.39 | $997K | -64% | plan |
| Mar 2, 2026 | Welgus Howard G.D | ▼ Sale | 10,000 | $25.65 | $257K | -16.7% | plan |
| Mar 2, 2026 | Edwards Larry ToddSee Remarks · O | ▼ Sale | 3,687 | $25.18 | $93K | -2.1% | plan · 2 tranches |
| Mar 2, 2026 | Watanabe ToddSee Remarks · O·D | ▼ Sale | 37,349 | $25.18 | $941K | -4.5% | plan · 2 tranches |
| Mar 2, 2026 | Matsuda MasaruSee Remarks · O | ▼ Sale | 12,058 | $26.03 | $314K | -8.1% | plan · 4 tranches |
| Mar 2, 2026 | Vairavan LathaSVP Chief Financial Officer · O | ▼ Sale | 2,853 | $25.18 | $72K | -3.1% | plan · 2 tranches |
| Mar 2, 2026 | Burnett PatrickSee Remarks · O | ▼ Sale | 6,287 | $25.18 | $158K | -4.9% | plan · 2 tranches |
| Feb 4, 2026 | Burnett PatrickSee Remarks · O | ▼ Sale | 13,469 | $25.72 | $346K | -14.3% | plan · 2 tranches |
| Feb 2, 2026 | Matsuda MasaruSee Remarks · O | ▼ Sale | 40,638 | $25.28 | $1.0M | -27% | plan · 4 tranches |
| Feb 2, 2026 | Watanabe ToddSee Remarks · O·D | ▼ Sale | 19,833 | $25.5 | $506K | -2.7% | plan |
| Feb 2, 2026 | Vairavan LathaSVP Chief Financial Officer · O | ▼ Sale | 1,320 | $25.5 | $34K | -2% | plan |
| Feb 2, 2026 | Welgus Howard G.D | ▼ Sale | 10,000 | $25.05 | $250K | -14.3% | plan |
| Feb 2, 2026 | Edwards Larry ToddSee Remarks · O | ▼ Sale | 2,052 | $25.5 | $52K | -1.4% | plan |
| Jan 5, 2026 | Burnett PatrickSee Remarks · O | ▼ Sale | 2,490 | $28.98 | $72K | -2.6% | plan |
| Jan 2, 2026 | Welgus Howard G.D | ▼ Sale | 10,000 | $28.96 | $290K | -12.5% | plan |
| Dec 31, 2025 | Burnett PatrickSee Remarks · O | ▼ Sale | 1,697 | $29.2 | $50K | -1.7% | plan · 2 tranches |
| Dec 15, 2025 | Burnett PatrickSee Remarks · O | ▼ Sale | 11,500 | $28.94 | $333K | -10.5% | plan |
| Dec 1, 2025 | Welgus Howard G.D | ▼ Sale | 10,000 | $30.21 | $302K | -11.1% | plan |
| Dec 1, 2025 | Matsuda MasaruSee Remarks · O | ▼ Sale | 1,657 | $30.23 | $50K | -1.1% | plan |
| Nov 24, 2025 | LIN SUE-JEAND | ▼ Sale | 25,272 | $30.78 | $778K | -48.6% | — |
| Nov 24, 2025 | Watanabe ToddSee Remarks · O·D | ▼ Sale | 50,000 | $30.35 | $1.5M | -6.3% | plan · 2 tranches |
| Nov 20, 2025 | Gilbert Halley ED | ▼ Sale | 16,532 | $27.55 | $455K | -42.8% | — |
| Nov 19, 2025 | Matsuda MasaruSee Remarks · O | ▼ Sale | 2,550 | $28.29 | $72K | -1.7% | plan · 2 tranches |
| Nov 13, 2025 | Krishnamohan NehaD | ▼ Sale | 40,504 | $23.2 | $939K | -64.7% | plan · 2 tranches |
| Nov 6, 2025 | Edwards Larry ToddSee Remarks · O | ▼ Sale | 29,131 | $25.16 | $733K | -16.2% | — |
| Nov 6, 2025 | Burnett PatrickSee Remarks · O | ▼ Sale | 17,250 | $24.18 | $417K | -14.9% | plan |
| Nov 5, 2025 | Burnett PatrickSee Remarks · O | ▼ Sale | 6,486 | $24.12 | $156K | -6.2% | plan · 3 tranches |
| Nov 3, 2025 | Vairavan LathaSVP Chief Financial Officer · O | ▼ Sale | 88 | $24.72 | $2K | -0.1% | plan |
| Nov 3, 2025 | Watanabe ToddSee Remarks · O·D | ▼ Sale | 11,547 | $24.72 | $285K | -1.4% | plan · 2 tranches |
| Nov 3, 2025 | Welgus Howard G.D | ▼ Sale | 10,000 | $25.27 | $253K | -10% | plan |
Every $ARQT filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Arcutis Biotherapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ARQT feed.